-  This bill is not active in this session.
 
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A07338 Summary:

BILL NOA07338
 
SAME ASSAME AS S06542
 
SPONSORPaulin
 
COSPNSRWeprin
 
MLTSPNSR
 
Amd 2500-a, Pub Health L
 
Removes limitations on newborn screening for glucose-6-phosphate dehydrogenase deficiency.
Go to top    

A07338 Actions:

BILL NOA07338
 
05/17/2023referred to health
05/23/2023reported referred to ways and means
06/05/2023reported referred to rules
06/20/2023reported
06/20/2023rules report cal.866
06/20/2023substituted by s6542
 S06542 AMEND= RIVERA
 04/26/2023REFERRED TO HEALTH
 05/17/2023REPORTED AND COMMITTED TO FINANCE
 06/01/2023COMMITTEE DISCHARGED AND COMMITTED TO RULES
 06/01/2023ORDERED TO THIRD READING CAL.1527
 06/07/2023PASSED SENATE
 06/07/2023DELIVERED TO ASSEMBLY
 06/07/2023referred to ways and means
 06/20/2023substituted for a7338
 06/20/2023ordered to third reading rules cal.866
 06/20/2023passed assembly
 06/20/2023returned to senate
 12/12/2023DELIVERED TO GOVERNOR
 12/22/2023VETOED MEMO.143
 04/26/2023REFERRED TO HEALTH
 05/17/2023REPORTED AND COMMITTED TO FINANCE
 06/01/2023COMMITTEE DISCHARGED AND COMMITTED TO RULES
 06/01/2023ORDERED TO THIRD READING CAL.1527
 06/07/2023PASSED SENATE
 06/07/2023DELIVERED TO ASSEMBLY
 06/07/2023referred to ways and means
 06/20/2023substituted for a7338
 06/20/2023ordered to third reading rules cal.866
 06/20/2023passed assembly
 06/20/2023returned to senate
 12/12/2023DELIVERED TO GOVERNOR
 12/22/2023VETOED MEMO.143
Go to top

A07338 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A7338
 
SPONSOR: Paulin
  TITLE OF BILL: An act to amend the public health law, in relation to newborn screening for glucose-6-phosphate dehydrogenase deficiency   PURPOSE OR GENERAL IDEA OF BILL:: Requires glucose-6-phosphate dehydrogenase deficiency testing for all newborns.   SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends paragraph (j) of subdivision 1 of section 2500-a of the public health law by removing the requirements that limit testing of glucose-6-phosphate dehydrogenase deficiency in newborns. Section 2 provides the effective date   JUSTIFICATION: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited genetic enzyme disorder that affects the functioning of red blood cells and has the potential to cause attacks of acute hemolytic anemia, severe neonatal jaundice, and kernicterus, which is caused by high levels of bilirubin and can affect brain development. In the most severe cases, untreated G6PD deficiency leads to permanent brain damage and sometimes death. Under current law, there are certain conditions for newborns to qualify for the G6PD screening. The law requires newborns to already be showing symptoms of hemolytic anemia, severe jaundice, or be at an ethnic risk by having African, Asian, Mediterranean, or Middle Eastern ances- try.Waiting until symptoms are present before screening for G6PD defi- ciency, can lead to severe complications for the baby. When checking a newborn for G6PD, bilirubin levels can also be checked before it reaches harmful levels. Currently, bilirubin levels aren't checked until after the damage has been done. Additionally, by separating this screening out from other newborn screenings the process to perform the task is made more complicated, and it is more invasive to the infant-patient. With New York being such a diverse state, G6PD should be a requirement for newborn screening regardless if symptoms are present or not. Removing the preconditions requirement for G6PD testing will ensure that newborns receive timely treatment that is needed to avoid further complications.   PRIOR LEGISLATIVE HISTORY:: New Bill   FISCAL IMPLICATIONS:: Minimal   EFFECTIVE DATE:: This act shall take effect immediately
Go to top

A07338 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7338
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                      May 17, 2023
                                       ___________
 
        Introduced by M. of A. PAULIN -- read once and referred to the Committee
          on Health
 
        AN  ACT to amend the public health law, in relation to newborn screening
          for glucose-6-phosphate dehydrogenase deficiency
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Paragraph  (j)  of subdivision 1 of section 2500-a of the
     2  public health law, as amended by chapter 70 of  the  laws  of  2022,  is
     3  amended to read as follows:
     4    (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative
     5  enzymatic  test  or  other  diagnostic  test in cases where: the newborn
     6  infant presents with hemolytic anemia, hemolytic jaundice, or  early-on-
     7  set  increasing  neonatal  jaundice,  that is, jaundice (bilirubin level
     8  greater than fortieth percentile for age in hours) persisting beyond the
     9  day of birth through the week after birth; the newborn infant  has  been
    10  admitted to the hospital for jaundice following birth; or the biological
    11  parent  of the newborn infant indicates a family, racial, or ethnic risk
    12  of  glucose-6-phosphate  dehydrogenase  deficiency,   including   having
    13  significant African, Asian, Mediterranean, or Middle Eastern ancestry].
    14    § 2. This act shall take effect immediately.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10869-02-3
Go to top